Buparvaquone
From Wikipedia, the free encyclopedia
Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. It is a promising compound for the therapy and prophylaxis of all forms of theileriosis. Buparvaquone has been shown to have anti-leishmanial activity in vitro. CAS:88426-32-9
 |
This antimicrobial-related article is a stub. You can help Wikipedia by expanding it. |
